From: The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Events
RR
95% CI
Myocardial infarction
0.96
0.48-1.90
Stroke
1.25
0.47-3.31
Deep venous thrombosis
0.77
0.37-1.61
Renal failure
0.73
0.16-3.32